As the COVID-19 pandemic spread across the globe in early 2020, its impact on M&A volume was immediate, and recalibrated the ways in which buyers and sellers analyze and value targets. 

My colleagues and I have released a new article as part of A&M's Your Next Deal Will Be Different series discussing common COVID-19 adjustments that buyers and sellers are making to EBITDA, trends in valuation and forecasts, and trends in contingent consideration provisions. 

I invite you to download our article and reach out to discuss your own corporate deal strategy.